Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.71 EUR | +1.28% | +7.13% | +12.53% |
Apr. 26 | Transcript : Terveystalo Oyj, Q1 2024 Earnings Call, Apr 26, 2024 | |
Apr. 26 | Terveystalo Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Analyst opinion has improved significantly over the past four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.53% | 1.18B | B- | ||
-18.46% | 16.57B | B+ | ||
+4.50% | 12.43B | B | ||
+4.98% | 11.69B | B+ | ||
+4.33% | 10.24B | B+ | ||
-3.10% | 7.59B | A- | ||
+20.21% | 7.15B | D | ||
+6.45% | 6.8B | B- | ||
+50.68% | 4.65B | - | ||
-5.12% | 4.22B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- TTALO Stock
- Ratings Terveystalo Oyj